Repligen Corp (RGEN) Swings to Q1 Profit of 4c/Share
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.49 +1.08%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.04, versus ($0.07) reported last year. Revenue for the quarter came in at $12.84 million versus the consensus estimate of $7 million.
For earnings history and earnings-related data on Repligen Corp (RGEN) click here.
For earnings history and earnings-related data on Repligen Corp (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
